unmet need in the medical literature. We took this challenge on from a completely altruistic point of view by self-publishing to ensure that our authors were never charged anything to publish in JAMS. As a result, operation of the journal required tremendous effort from our
Dear JAMS authors, reviewers, contributors, and the stewardship community,
First and foremost we would like to thank you for your tremendous and
overwhelming support of JAMS. Developing a journal devoted to antimicrobial
stewardship was important to us as clinicians to fill an
of this tweet. Authors who currently have manuscripts in process in JAMS will have those manuscripts returned or they may withdraw them so that they can be submitted elsewhere. This also applies to authors who had papers published in the first edition of JAMS.
STUDY published in @JAMS_Journal shows patients detected with the T2Candida Panel were treated more than 8x faster https://t.co/4BHFiK4SfZ #Diagnostics#MedTech
@EB_Hirsch@mmPharmD@ErinMcCreary@TheIDApprentice We appreciate your contribution to the journal. We have 15 manuscripts in review right now and need your support to give our authors timely response times and maintain the quality of our publications